Pro-dopamine effects of neurotensin on sensorimotor gating deficits

Peptides

Volumn 18, Issue 9, 1997, Pages 1457-1460

  Feifel, David ^a,b   Reza, Tammi L ^a   Robeck, Stephanie L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

Dopamine; Neurotensin; Nucleus accumbens; Prepulse inhibition; Sensorimotor gating

Indexed keywords

DOPAMINE; NEUROTENSIN;

ANIMAL EXPERIMENT; ARTICLE; CHANNEL GATING; DOPAMINE BRAIN LEVEL; MALE; MOTOR DYSFUNCTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORY DYSFUNCTION;

ACOUSTIC STIMULATION; AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NEURAL INHIBITION; NEUROTENSIN; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION;

EID: 0030715364     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00187-3     Document Type: Article

References (15)

1. Braff D. L., Geyer M. A. Sensorimotor gating and schizophrenia Human and animal model studies . Arch. Gen. Psychiat. 47:1990;181-188.
2. Ervin G. N., Birkemo L. S., Nemeroff C. V., Prange A. J. Jr. Neurotensin blocks certain amphetamine-induced behaviors. Nature. 291:1981;73-76.
3. Feifel D., Minor K. L., Dulawa S. C., Swerdlow N. R. The effects of intra-accumbens neurotensin on sensorimotor gating. Brain Res. 760:1997;80-84.
4. Hokfelt T., Everitt B. J., Theodorsson-Norheim E., Goldstein M. Occurence of neurotensin-like immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons. J. Comp. Neurol. 222:1984;543-559.
5. Jolicoeur F. B., Rivest R., St-Pierre S., Gagne M. A., Dumais M. The effects of neurotensin and [D-Tyr11]-NT on the hyperactivity induced by intra-accumbens administration of a potent dopamine receptor agonist. Neuropeptides. 6:1985;143-156.
6. Kalivas P. W., Nemeroff C. B., Prange A. J. Jr. Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin. Eur. J. Pharmacol. 78:1982;471-474.
7. Le F., Cusack B., Richelson E. The neurotensin receptor Is there more than one subtype? TIPS. 17:1996;1-3.
8. Manberg P. J., Youngblood W. W., Nemeroff C. B., Rossor M. N., Iversen L. L., Prange A. J. Jr, Kizer J. S. Regional distribution of neurotensin in human brain. J. Neurochem. 38:1982;1777-1780.
9. Nemeroff C. B., Levant B., Myers B., Bissette G. Neurotensin, antipsychotic drugs, and schizophrenia. Ann. NY Acad. Sci. 668:1992;147-156.
10. Pellegrino, L. J.; Pellegrino, A. S.; Cushman, A. S. A stereotaxic atlas of the rat brain. New York: Plenum Press; 1979.
11. Robledo R., Maldonado R., Koob G. F. Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not atttenuate cocaine self-administration in the rat. Brain Res. 622:1993;105-112.
12. Steinberg R., Brun P., Fournier M., Souilhac J., Rodier D., Mons G., Terranova P., Le Fur G., Soubrie P. SR4892, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behavior and changes in dopaminergic transmission. Neurosci. 59:1994;921-929.
13. Skoog K. M., Cain S. T., Nemeroff C. B. Centrally administered neurotensin suppresses locomotor hyperactivity induced by d-amphetamine but not by scopolamine or caffeine. Neuropharmacology. 25:1986;777-782.
14. Swerdlow N. R., Caine S. B., Braff D. L., Geyer M. A. The neural substrates of sensorimotor gating of the startle reflex A review of recent findings and their implications . J. Psychopharmacol. 6:1992;176-190.
15. Swerdlow N. R., Braff D. L., Taaid N., Geyer M. A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch. Gen. Psychiatry. 51:1994;139-154.